Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort

Abstract Background The evidence regarding effects of statins on exacerbation risk in COPD remains controversial. Previous studies often excluded patients with cardiovascular comorbidities despite their high prevalence in COPD and role for exacerbations. Based on the cardioprotective properties of s...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	N. Frantzi, X. P. Nguyen, C. Herr, P. Alter, S. Söhler, D. Soriano, H. Watz, B. Waschki, F. Trinkmann, M. Eichenlaub, F. C. Trudzinski, J. D. Michels-Zetsche, A. Omlor, F. Seiler, I. Moneke, F. Biertz, G. Rohde, D. Stolz, T. Welte, H. U. Kauczor, K. Kahnert, R. A. Jörres, C. F. Vogelmeier, R. Bals, S. Fähndrich, on behalf of the German COSYCONET Cohort
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2024-05-01
Reeks:	Respiratory Research
Onderwerpen:	Statins COPD Exacerbations Cardiovascular comorbidities
Online toegang:	https://doi.org/10.1186/s12931-024-02822-1
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!